Direxion Daily Healthcare Bull 3x Shares Rating $128.71 -2.17 (-1.66%) As of 01:53 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock Direxion Daily Healthcare Bull 3x Shares Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CURE Aggregate RatingModerate Buy 2.77Holdings in CURE have an aggregate rating of Moderate Buy based on 459 analyst ratings issued in the past year covering 18 companies (51.1% of the portfolio).CURE Aggregate Price Target$128.760.04% UpsideHigh Prediction$128.76Average Prediction$128.76Low Prediction$128.76Holdings in CURE have an aggregate price target of $128.76 and a range of $128.76 to $128.76 covering 18 companies (51.1% of the portfolio).CURE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Healthcare Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 18 CURE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.02%LLYEli Lilly and Company$1,182.99-2.2%4.8606 of 5 stars2.83$1,292.18 9.2%30Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision6.96%JNJJohnson & Johnson$260.92-0.4%4.8074 of 5 stars2.80$268.22 2.8%25Trending News4.89%ABBVAbbVie$249.39-0.6%4.9053 of 5 stars2.88$275.50 10.5%26Trending NewsAnalyst ForecastAnalyst Revision4.20%UNHUnitedHealth Group$401.02+0.5%4.9377 of 5 stars2.89$455.92 13.7%27Dividend Announcement3.59%MRKMerck & Co., Inc.$135.10-0.3%4.373 of 5 stars2.68$135.50 0.3%22Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.39%AMGNAmgen$413.00-1.2%3.8123 of 5 stars2.35$372.39 -9.8%31Analyst ForecastInsider Trade2.38%TMOThermo Fisher Scientific$592.43-0.6%4.64 of 5 stars2.79$619.41 4.6%24Insider Trade2.08%ABTAbbott Laboratories$111.39+0.1%4.6814 of 5 stars2.96$118.67 6.5%27Positive NewsAnalyst Upgrade1.91%GILDGilead Sciences$137.93-0.2%4.4525 of 5 stars2.83$158.04 14.6%29Trending NewsAnalyst DowngradeOptions VolumeAnalyst Revision1.64%PFEPfizer$26.83+0.1%3.6971 of 5 stars2.19$28.28 5.4%21Trending NewsAnalyst Revision1.53%BMYBristol Myers Squibb$64.08-0.9%4.219 of 5 stars2.52$66.06 3.1%25Trending NewsAnalyst Revision1.51%CVSCVS Health$96.69+1.8%4.8586 of 5 stars2.92$106.75 10.4%24Positive NewsAnalyst Forecast1.48%ISRGIntuitive Surgical$398.30-0.7%4.6426 of 5 stars2.68$508.68 27.7%31Positive NewsAnalyst UpgradeInsider TradeGap Up1.39%DHRDanaher$203.27-0.3%4.399 of 5 stars2.84$228.91 12.6%251.38%VRTXVertex Pharmaceuticals$507.23-1.8%4.4301 of 5 stars2.92$563.50 11.1%241.32%SYKStryker$339.46-0.5%4.8911 of 5 stars2.79$386.28 13.8%24Positive NewsAnalyst Downgrade1.26%MDTMedtronic$91.55+1.1%4.7211 of 5 stars2.67$98.83 8.0%27Positive NewsUpcoming EarningsOptions Volume1.13%MCKMcKesson$863.24+0.8%4.9216 of 5 stars2.82$977.00 13.2%17Analyst ForecastInsider Trade This page (NYSEARCA:CURE) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredCentral banks bought 710 tonnes - this fund pays monthlyGold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredGold buyout deals have handed shareholders overnight gains up to 79 percentGold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...Golden Portfolio | SponsoredWho Really Gets Rich from IPOs?Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...Weiss Ratings | SponsoredHow a rare metal shortage sent gains up 2512 percentIn 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...Awesomely | Sponsored$100 for this… $500 for that. Here’s how to stop the bleeding todayRising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Healthcare Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Healthcare Bull 3x Shares With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.